Table 4.
Laboratory values prior to treatment and after each PRRT cycle.
| Laboratory test mean ± SD (min–max) | n | Prior to treatment (baseline) | n | Postcycle 1 | n | Postcycle 2 | n | Postcycle 3 | n | Postcycle 4 |
| Cr (mg/dL) | 28 | 0.97±0.39 (0.33–1.94) | 12 | 1.03 ± 0.38 (0.40–1.80) | 12 | 0.83 ± 0.35 (0.31–1.50) | 10 | 0.93 ± 0.26 (0.56–1.30) | 7 | 0.75 ± 0.32 (0.20–1.20) |
| HgB (g/dL) | 28 | 12.14 ± 1.72 (6.10–15.00) | 9 | 11.10 ± 3.35 (3.5–14.90) | 12 | 11.88 ± 1.34 (9.60–13.70) | 10 | 10.49 ± 1.51 (8.50–13.50) | 8 | 11.45 ± 2.13 (8.90–15.30) |
| WBC (×109 cells/L) | 27 | 6.11 ± 1.81 (3.40–10.0) | 12 | 6.21 ± 2.12 (4.10–11.80) | 12 | 5.45 ± 3.61 (2.50–16.00) | 10 | 4.27 ± 1.64 (2.30–7.40) | 8 | 5.31 ± 1.86 (4.00–9.80) |
| Platelet count (cells/mL) | 27 | 221.89 ± 89.58 (93.00–449.00) | 12 | 227.83 ± 114.66 (125.00–521.00) | 12 | 202.33 ± 86.55 (92.00–346.00) | 10 | 190.70 ± 96.16 (51.00–334.00) | 8 | 167.00 ± 82.68 (66.00–326.00) |
| Total bilirubin (mg/dL) | 27 | 0.60 ± 0.42 (0.10–1.90) | 11 | 0.41 ± 0.12 (0.20–0.60) | 12 | 0.59 ± 0.43 (0.30–1.90) | 11 | 0.59 ± 0.44 (0.30–1.80) | 8 | 0.69 ± 0.41 (0.20–1.40) |
| eGFR (mL/min/1.73 m2) | 23 | 64.31 ± 17.67 (35.0–105.0) | 10 | 67.85 ± 22.16 (33.90–112.00) | 11 | 73.87 ± 22.12 (55.00–114.00) | 10 | 74.00 ± 20.56 (60.00–111.00) | 8 | 61.14 ± 14.00 (49.20–94.00) |
Cr = creatinine, eGFR = estimated glomerular filtration rate, HgB = hemoglobin, max = maximum, min = minimum, PRRT = peptide receptor radionuclide therapy, SD = standard deviation, WBC = white blood cell.